The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake

Life Sciences

Volumn 62, Issue 4, 1997, Pages 351-363

  Romero, J ^a   De Miguel, R ^a   Ramos, J A ^a   Fernandez Ruiz J J ^a  

^a Inst Univ de Drogodependencias   (Spain)

Author keywords

Cannabinoid receptor; GABA; Striatonigral GABAergic neurons; 9 tetrahydrocannabinol

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; CANNABINOID; CANNABINOID RECEPTOR; DEXANABINOL; GLUTAMATE DECARBOXYLASE; RIMONABANT; TETRAHYDROCANNABINOL;

4 AMINOBUTYRIC ACID UPTAKE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN REGION; CONTROLLED STUDY; ELECTROCHEMICAL DETECTION; ENZYME ACTIVITY; GABAERGIC SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; SUBSTANTIA NIGRA; SYNAPTOSOME;

ANIMALIA; CANNABIS;

EID: 0031578879     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)01117-X     Document Type: Article

References (52)

1. PERTWEE R.G., GREENTREE S.G., SWIFT P.A. Neuropharmacology. 27:1988;1256-1270.
2. NAVARRO M., FERNANDEZ-RUIZ J.J., DE MIGUEL R., HERNANDEZ M.L., CEBEIRA M., RAMOS J.A. Pharmacol. Biochem. Behav. 45:1993;291-298.
3. MOSS D.F., McMASTER S.B., ROGERS J. Pharmacol. Biochem. Behav. 15:1981;779-783.
4. RODRIGUEZ DE FONSECA F., GORRITI M.A., FERNANDEZ-RUIZ J.J., PALOMO T., RAMOS J.A. Pharmacol. Biochem. Behav. 47:1994;33-40.
5. FRIDE E., MECHOULAM R. Eur. J. Pharmacol. 231:1993;313-314.
6. CRAWLEY J.N., CORWIN R.L., ROBINSON J.K., FELDER C.C., DEVANE W., AXELROD J. Pharmacol. Biochem. Behav. 46:1993;967-972.
7. WICKENS A.P., PERTWEE R.G. Eur. J. Pharmacol. 250:1993;205-208.
8. SMITH P.B., COMPTON D.R., WELCH S.P., RAZDAN R.K., MECHOULAN R., MARTIN B.R. J. Pharmacol. Exp. Ther. 270:1994;219-227.
9. RODRIGUEZ DE FONSECA F., FERNANDEZ-RUIZ J.J., MURPHY L.L., CEBEIRA M., STEGER R.W., BARTKE A., RAMOS J.A. Pharmacol. Biochem. Behav. 42:1992;269-275.
10. MECHOULAM R., HANUS L., MARTIN B.R. Biochem. Pharmacol. 48:1994;1537-1544.
11. HERKENHAM M., LYNN A.B., LITTLE M.D., JOHNSON M.R., MELVIN L.S., DE COSTA B.R., RICE K.C. Proc. Nat. Acad. Sci. (USA). 87:1990;1932-1936.
12. HERKENHAM M., LYNN A.B., JOHNSON M.R., MELVIN L.S., DE COSTA B.R., RICE K.C. J. Neurosci. 11:1991;563-583.
13. HOWLETT A.C., BIDAUT-RUSSELL M., DEVANE W.A., MELVIN L.S., JOHNSON M.R., HERKENHAM M. Trends Neurosci. 13:1990;420-423.
14. HERKENHAM M., LYNN A.B., DE COSTA B.R., RICHFIELD E.K. Brain Res. 547:1991;267-274.
15. GERFEN Ch.R. Sem. Neurosci. 4:1992;109-118.
16. ROMERO J., GARCIA-PALOMERO E., FERNANDEZ-RUIZ J.J., RAMOS J.A. Behav. Pharmacol. 7:1996;299-302.
17. MANEUF Y.P., CROSSMAN A.R., BROTCHIE J.M. Synapse. 22:1996;382-385.
18. GLASS M., FAULL R.L.M., DRAGUNOW M. Neuroscience. 56:1993;523-527.
19. RICHFIELD E.K., HERKENHAM M. Ann. Neurol. 36:1994;577-584.
20. R.G. PERTWEE, Cannabinoid receptors. Academic Press, pp. 1-34 (1995).
21. ACETO M.D., SCATES S.M., LOWE J.A., MARTIN B.R. Eur. J. Pharmacol. 282:1995;R1-R2.
22. TSOU K., PATRICK S.L., WALKER J.M. Eur. J. Pharmacol. 280:1995;R13-R15.
23. ROMERO J., GARCIA L., CEBEIRA M., ZADROZNY D., FERNANDEZ-RUIZ J.J., RAMOS J.A. Life Sci. 56:1995;2033-2040.
24. ROMERO J., DE MIGUEL R., GARCIA-PALOMERO E., FERNANDEZ-RUIZ J.J., RAMOS J.A. Brain Res. 694:1995;223-232.
25. ROMERO J., GARCIA-PALOMERO E., LIN S.Y., RAMOS J.A., MAKRIYANNIS A., FERNANDEZ-RUIZ J.J. Life Sci. 58:1996;1249-1257.
26. ABADJI V., LIN S., TAHA G., GRIFFIN G., STEVENSON L.A., PERTWEE R.G., MAKRIYANNIS A. J. Med. Chem. 37:1994;1889-1893.
27. BOLAM J.P., SMITH Y. Brain Res. 529:1990;57-78.
28. SANTIAGO M., WESTERINK B.H.C. Eur. J. Pharmacol. 219:1992;175-181.
29. SMITH Y., BOLAM J.P. Brain Res. 493:1989;160-167.
30. MAILLEUX P., VANDERHAEGHEN J.J. Neuroscience. 48:1992;655-668.
31. TEPPER J.M., MARTIN L.P., ANDERSON D.R. J. Neurosci. 15:1995;3092-3103.
32. SAÑUDO-PEÑA, WALKER J.M. J. Neurophysiol. 77:1997;1635-1638.
33. WOOD P.L., ALTAR C.A. Pharmacol. Rev. 40:1988;163-187.
34. REID M.S., HERRERA-MARSCHITZ M., HOKFELT T., TERENIUS L., UNGERSTEDT U. Eur. J. Pharmacol. 147:1988;411-420.
35. ARIAS-MONTAÑO J.A., MARTINEZ-FONG D., ACEVES J. Neuropharmacology. 30:1991;1047-1052.
36. ARIAS-MONTAÑO J.A., MARTINEZ-FONG D., ACEVES J. Eur. J. Pharmacol. 218:1992;335-338.
37. M. PALKOVITS and J. BROWNSTEIN, Maps and Guide to Microdissection of the rat brain. Elsevier, pp. 6 (1988).
38. SMITH S., SHARP T. J. Chromat. 652:1994;228-233.
39. NICOLETTI F., GRANDISON L., MEEK J.L. J. Neurochem. 44:1985;1217-1220.
40. NAVARRO M., FERNANDEZ-RUIZ J.J., DE MIGUEL R., HERNANDEZ M.L., CEBEIRA M., RAMOS J.A. Behav. Brain Res. 57:1993;37-46.
41. WHITTAKER V.P., MICHAELSON I.A., KIRKLAND R.J.A. Biochem. J. 90:1964;293-303.
42. R.G. PERTWEE, Neurobiology and neurophysiology of cannabinoids. Biochemistry and physiology of substance abuse. CRC Press, pp. 165-219 (1992).
43. BANERJEE S.P., SNYDER S.H., MECHOULAM R. J. Pharmacol. Exp. Ther. 194:1975;74-81.
44. HERSCHKOWITZ M., GOLDMAN R., RAZ A. Biochem. Pharmacol. 26:1977;1327-1334.
45. REVUELTA A.V., CHENEY D.L., COSTA E. Life Sci. 30:1982;1841-1846.
46. LEADER J.P., KOE B.K., WEISSMAN A. J. Clin. Pharmacol. suppl. 21:1981;262S-270S.
47. GALE K.N., GUIDOTTI A. Nature. 262:1976;691-693.
48. MILLER A.S., WALKER J.M. Eur. J. Pharmacol. 279:1995;179-185.
49. MANEUF Y.P., NASH J.E., CROSSMAN A.R., BROTCHIE J.M. Eur. J. Pharmacol. 308:1996;161-164.
50. SAÑUDO-PEÑA M.C., PATRICK S.L., PATRICK R.L., WALKER J.M. Neurosci. Lett. 206:1996;21-24.
51. CHU D.C.M., ALBIN R.L., YOUNG A.B., PENNEY J.B. Neuroscience. 34:1990;341-357.
52. TIAN Y., KAPATOS G., GRANNEMAN J.G., BANNON M.J. Neurosci. Lett. 173:1994;143-146.